NCT07248904 The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions
| NCT ID | NCT07248904 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cukurova University |
| Condition | Human Papillomavirus (HPV) |
| Study Type | INTERVENTIONAL |
| Enrollment | 88 participants |
| Start Date | 2026-01-16 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 88 participants in total. It began in 2026-01-16 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to examine the impact of a structured educational program based on the Transtheoretical Model (TTM) on HPV knowledge, health beliefs, and vaccination behavioral intentions among first-year nursing students. The study will also evaluate how the intervention affects students' HPV vaccine readiness compared to the TTM. The primary questions addressed by the study are: * Does the TTM-based educational intervention increase students' knowledge about HPV and the HPV vaccine? * Does the program change students' health beliefs regarding susceptibility, severity, benefits, and barriers to HPV and the HPV vaccine? * Does the program improve students' intentions and readiness to receive the HPV vaccine? * Do students move to a higher behavioral readiness stage (from Precontemplation to Contemplation, Preparation, Action, or Maintenance) after the intervention? The researcher will compare the TTM-based educational intervention with a control group that did not receive structured education to determine whether a personalized, stage-based approach is more effective in improving HPV-related outcomes among nursing students. Participants will: * Complete baseline questionnaires measuring HPV knowledge, health beliefs, and vaccination intention. * The experimental group (intervention group) will receive personalized TTM-based education, face-to-face instruction in modules aligned with the five TTM phases (Precontemplation, Contemplation, Preparation, Action, and Maintenance). * The experimental group will participate in educational sessions designed to raise awareness, correct misinformation, support decision-making, and encourage protective behaviors. * The control group will not receive any educational program. * All participants in the experimental and control groups will complete the same questionnaires again to assess changes after the intervention. The TTM-based educational intervention provides: * Staged counseling * Information about HPV and the HPV vaccine * Activities to raise awareness, strengthen motivation, and support vaccination adoption * Personalized feedback based on student readiness * Structured modules focusing on knowledge, belief, and behavior change strategies The study population included first-year nursing students enrolled in the Faculty of Health Sciences. A total of 88 participants will be recruited and randomly assigned to either the intervention (n=44) or control (n=44) groups through simple randomization. The results of this study are expected to contribute to the development of evidence-based education strategies in nursing, support of behavioral change models in health education, and strengthen the role of future nurses in HPV prevention, vaccine advocacy, and public health practice.
Eligibility Criteria
Inclusion Criteria: * First-year students enrolled in the Nursing Department of the Faculty of Health Sciences * Provide written informed consent to participate * Agree to attend all educational sessions and data collection appointments during the study period * Have sufficient Turkish literacy to read and understand study materials * Have not previously received any comprehensive education about HPV infection or HPV vaccination Exclusion Criteria: * Students who do not agree to participate in the study * Students who do not provide written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07248904 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Human Papillomavirus (HPV). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07248904 currently recruiting?
Yes, NCT07248904 is actively recruiting participants. Contact the research team at mujjde_@hotmail.com for enrollment information.
Where is the NCT07248904 trial being conducted?
This trial is being conducted at Adana, Turkey (Türkiye), Adana, Turkey (Türkiye).
Who is sponsoring the NCT07248904 clinical trial?
NCT07248904 is sponsored by Cukurova University. The trial plans to enroll 88 participants.